← Back
Data updated: Mar 10, 2026
INDCHEMIE HEALTH
Infectious DiseaseCardiovascularGastroenterology
INDCHEMIE HEALTH is a generic drug manufacturer focused on Infectious Disease, Cardiovascular, Gastroenterology. Key products include ESOMEPRAZOLE MAGNESIUM.
2015
Since
2
Drugs
-
Trials
36
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
NEBIVOLOL HYDROCHLORIDE 2025-08-01
Labeling
NEBIVOLOL HYDROCHLORIDE 2025-08-01
Labeling
ESOMEPRAZOLE MAGNESIUM 2025-04-15
ESOMEPRAZOLE MAGNESIUM 2025-04-15
ESOMEPRAZOLE MAGNESIUM 2025-03-05
ESOMEPRAZOLE MAGNESIUM 2025-03-05
NEBIVOLOL HYDROCHLORIDE 2025-01-28
ESOMEPRAZOLE MAGNESIUM 2025-01-07
ESOMEPRAZOLE MAGNESIUM 2024-12-10
Labeling
ESOMEPRAZOLE MAGNESIUM 2024-12-10
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Infectious Disease 33%
1 drugs
Cardiovascular 33%
1 drugs
Gastroenterology 33%
1 drugs
Pipeline Strength Pro
Loading...
Competitors Pro
APOTHECON specialty
Infectious Disease, Cardiovascular, Gastroenterology
Pfizer big-pharma
Infectious Disease, Gastroenterology
WAYLIS THERAP big-pharma
Cardiovascular, Infectious Disease, Gastroenterology
Merck big-pharma
Infectious Disease, Cardiovascular
WARNER CHILCOTT LLC specialty
Cardiovascular, Gastroenterology, Infectious Disease
Active (1)
Discontinued (0)
Company Info
- First Approval
- 2015-07-29
- Latest
- 2024-08-27
- Applications
- 2